Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial

Table 3

Closure times for collagen/epinephrine and platelet counts in all STEMI patients and comparisons between ramipril and losartan treated STEMI patients after 8 weeks and six months of therapy.

Mean ± SD	All; ()	Ramipril; ()	Losartan; ()	Control; ()
After 8-week treatment
CT (sec)	239.8 ± 73.5	235.7 ± 84.6	244.7 ± 59.4	158.1 ± 80.3
Platelet count (1 × 10^9/L)	202.5 ± 85.7	190.7 ± 47.5	216.7 ± 116.2	278.6 ± 158.1
After 6-month treatment
CT (sec)	226.7 ± 80.3	226.9 ± 76.8	226.3 ± 85.0	158.1 ± 80.3
Platelet count (1 × 10^9/L)	195 ± 70.9	190.9 ± 44.3	199.3 ± 91.6	278.6 ± 158.1

CT: closure time for collagen/epinephrine; there is a statistically significant value (<0.05) between the control group and other groups.